Literature DB >> 33647465

Vedolizumab Therapy in Refractory Microscopic Colitis: A Single Center Case Series.

Lindsey C Shipley1, Sujan Ravi2, Kirk B Russ2, Frederick H Weber3.   

Abstract

Microscopic colitis (MC) is a disease characterized by chronic watery diarrhea secondary to colonic inflammation. Endoscopically, the mucosa is usually normal but biopsies show characteristic histologic findings.1.
Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33647465     DOI： 10.1016/j.cgh.2021.02.037

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


  3 in total

Review 1.  Microscopic colitis in older adults: impact, diagnosis, and management.

Authors:  Istvan Fedor; Eva Zold; Zsolt Barta
Journal:  Ther Adv Chronic Dis       Date:  2022-07-05       Impact factor: 4.970

2.  Microscopic colitis: Etiopathology, diagnosis, and rational management.

Authors:  Ole Haagen Nielsen; Fernando Fernandez-Banares; Toshiro Sato; Darrell S Pardi
Journal:  Elife       Date:  2022-08-01       Impact factor: 8.713

3.  Vedolizumab blocks α4β7 integrin-mediated T cell adhesion to MAdCAM-1 in microscopic colitis.

Authors:  Laura Besendorf; Tanja M Müller; Carol-Immanuel Geppert; Ines Schneider; Laura Mühl; Imke Atreya; Francesco Vitali; Raja Atreya; Markus F Neurath; Sebastian Zundler
Journal:  Therap Adv Gastroenterol       Date:  2022-06-28       Impact factor: 4.802
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.